C07D 491/113
With two or more oxygen atoms as ring hetero atoms in the
Official title: with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
C07D491/113 (With two or more oxygen atoms as ring hetero atoms in the) appears on 287 US grants and 446 published applications in this corpus.
Search patents in C07D- Granted patents
- 287
- Published applications
- 446
- Assignees
- 187
- Inventors
- 1,310
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 0 | 1 |
| 2002 | 0 | 0 |
| 2003 | 1 | 1 |
| 2004 | 0 | 6 |
| 2005 | 1 | 4 |
| 2006 | 2 | 10 |
| 2007 | 3 | 7 |
| 2008 | 2 | 11 |
| 2009 | 9 | 11 |
| 2010 | 3 | 14 |
| 2011 | 5 | 20 |
| 2012 | 13 | 31 |
| 2013 | 21 | 31 |
| 2014 | 29 | 35 |
| 2015 | 34 | 43 |
| 2016 | 26 | 28 |
| 2017 | 30 | 22 |
| 2018 | 21 | 25 |
| 2019 | 19 | 25 |
| 2020 | 14 | 19 |
| 2021 | 10 | 10 |
| 2022 | 10 | 19 |
| 2023 | 7 | 18 |
| 2024 | 14 | 21 |
| 2025 | 7 | 21 |
| 2026 | 6 | 13 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Pyrazolyl quinoxaline kinase inhibitors22 Sep 2026US 12,741,956 B2Astex Therapeutics Limited
- N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides8 Sep 2026US 12,729,196 B2AstraZeneca AB
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Compounds and methods for targeting pathogenic blood vessels28 Apr 2026US 12,612,385 B2Atengen, Inc.
- Additive mixtures for rheology modification of polymers7 Apr 2026US 12,595,343 B2BASF SE
- Imine compounds as well as preparation method therefor and use thereof27 Aug 2026US 2026/0248763 A1Bio Genuine (Shanghai) Biotech Co., Ltd
- Composition for preventing or treating cancer diseases comprising aryl-piperidine derivative20 Aug 2026US 2026/0242336 A1Korea Institute of Radiological & Medical Sciences
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- Negative allosteric modulators of metabotropic glutamate receptor 26 Aug 2026US 2026/0226019 A1Vanderbilt University
- Additive mixtures for rheology modification of polymers2 Jul 2026US 2026/0184859 A1BASF SE
Most cited
By later US patents
- Cyclic protein tyrosine kinase inhibitors134US 6,596,746 B1Bristol-Myers Squibb Company · 2003
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics101US 9,186,325 B2Tekmira Pharmaceuticals Corporation · 2015
- Processes and intermediates for making a JAK inhibitor72US 9,487,521 B2Incyte Corporation · 2016
- Prodrugs of fumarates and their use in treating various diseases69US 8,669,281 B1Alkermes Pharma Ireland Limited · 2014